Invention Grant
US09226952B2 Na/K-ATPase-derived peptide Src inhibitors and ouabain antagonists and uses thereof
有权
Na / K-ATP酶衍生肽Src抑制剂和哇巴因拮抗剂及其用途
- Patent Title: Na/K-ATPase-derived peptide Src inhibitors and ouabain antagonists and uses thereof
- Patent Title (中): Na / K-ATP酶衍生肽Src抑制剂和哇巴因拮抗剂及其用途
-
Application No.: US14195401Application Date: 2014-03-03
-
Publication No.: US09226952B2Publication Date: 2016-01-05
- Inventor: Zi-Jian Xie , Zhichuan Li , Joseph I. Shapiro
- Applicant: The University of Toledo
- Applicant Address: US OH Toledo
- Assignee: The University of Toledo
- Current Assignee: The University of Toledo
- Current Assignee Address: US OH Toledo
- Agency: MacMillan, Sobanski & Todd, LLC
- Main IPC: C07K4/00
- IPC: C07K4/00 ; A61K38/46 ; C07K14/47 ; C12N9/14 ; A61K38/00
Abstract:
A novel Src inhibitor that targets the Na/K-ATPase/Src receptor complex and antagonizes ouabain-induced protein kinase cascades and uses thereof are disclosed.
Public/Granted literature
- US20140187484A1 NA/K-ATPASE-DERIVED PEPTIDE SRC INHIBITORS AND OUABAIN ANTAGONISTS AND USES THEREOF Public/Granted day:2014-07-03
Information query
